What's fueling the biotech engine-2008

被引：45

作者：

Aggarwal, Saurabh

机构：

[1] Saurabh Aggarwal is a healthcare consultant based in New York.,

来源：

NATURE BIOTECHNOLOGY | 2009年 / 27卷 / 11期

关键词：

D O I：

10.1038/nbt1109-987

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Despite the global economic slowdown, biologics managed single-digit growth in 2008, driven mainly by continued high growth in sales of antibodies and insulins. Novel biologics in development look promising, but crowding, pricing and reimbursement are emerging as longer-term concerns.

引用

页码：987 / 993

页数：7

共 11 条

[1] What's fueling the biotech engine-2007 [J].

Aggarwal, Saurabh .

NATURE BIOTECHNOLOGY, 2008, 26 (11) :1227-1233

[2] What's fueling the biotech engine? [J].

Aggarwal, Saurabh .

NATURE BIOTECHNOLOGY, 2007, 25 (10) :1097-1104

[3]

BABBIT B, 2009, PRODUCT DEV STRATE 2

[4]

COHEN J, 2009, AM AC NEUR ANN M 200

[5] Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden [J].

Jonasson, J. M. ;

Ljung, R. ;

Talback, M. ;

Haglund, B. ;

Gudbjornsdottir, S. ;

Steineck, G. .

DIABETOLOGIA, 2009, 52 (09) :1745-1754

[6]

Kenneth R, 2009, BLOOD, V113, P4834

[7]

Leavitt M. O, 2008, DESIGN BUNDLED END S

[8] Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study [J].

Rosenstock, J. ;

Fonseca, V. ;

McGill, J. B. ;

Riddle, M. ;

Halle, J. P. ;

Hramiak, I. ;

Johnston, P. ;

Davis, M. .

DIABETOLOGIA, 2009, 52 (09) :1971-1973

[9] Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration [J].

Spaide, Richard F. ;

Laud, Ketan ;

Fine, Howard F. ;

Klancnik, James M., Jr. ;

Meyerle, Catherine B. ;

Yannuzzi, Lawrence A. ;

Sorenson, John ;

Slakter, Jason ;

Fisher, Yale L. ;

Cooney, Michael J. .

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (04) :383-390

[10]

*US GAO, 2006, BUNDL MED PAYM DRUGS

← 1 2 →